The 14th International Netherlands Cancer Institute
Head and Neck Cancer Symposium
Amsterdam, 4-5 April, 2019
The 14th Head & Neck Cancer symposium will focus on the diagnosis and treatment of locally advanced tumors. Many recent developments, such as continuing epidemiological research, new insights in molecular biology, more understanding of the role of HPV, advances in 3D technology and the breakthrough of immunotherapy have changed the approach of head and neck cancer dramatically during the last decades. These innovations may not only improve the outcome but also pose new challenges for multidisciplinary tumor boards in appropriate decision making.
This symposium brings pitfalls in implementation of these recent achievements in daily clinical practice to the attention of the participants. Lectures by keynote speakers will bring you up to date on general knowledge.
Case report discussions are included to discuss implementation of the acquired knowledge. Lectures and presentations aim at teaching and discussion on current advances and state of the art of diagnosis and treatment of head and neck cancer. The selection of the speakers represent the multidisciplinary character of this symposium.
The symposium is open for poster presentations dealing with controversies and multidisciplinary management in locally advanced head and neck tumors. During the coffee breaks on both conference days ‘Poster tours’ will be organized and all participants are stimulated to visit the posters. Faculty members will take responsibility for monitoring the discussion with attendees at the posters. Instructions for submission can be found here.
Who should attend?
The symposium is of importance for both residents and specialists working in the field of otolaryngology-head and neck surgery, oral and maxillofacial surgery, medical oncology, general surgery, radiotherapy, pathology, dermatology, radiology, speech and language pathology, fellows and residents in training.
International guest faculty
JP de Boer
MWM van den Brekel